Cargando…
Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
BACKGROUND: Bisphosphonate (BP) is an effective drug for the prevention and treatment of osteoporosis. However, gastrointestinal distress caused by BP is a well-known side effect for low compliance. The aim of our study was to compare the 1-year persistence, compliance and T-scores between the aperi...
Autores principales: | Park, Chan Ho, Jung, Ki Jin, Nho, Jae-Hwi, Kim, Ja-Hyung, Won, Sung Hun, Chun, Dong-Il, Byun, Dong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416146/ https://www.ncbi.nlm.nih.gov/pubmed/30899723 http://dx.doi.org/10.11005/jbm.2019.26.1.39 |
Ejemplares similares
-
Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
por: Nho, Jae-Hwi, et al.
Publicado: (2016) -
Atypical incomplete femoral neck fracture in patients taking long-term bisphosphonate: Case report, a report of 2 cases
por: Suh, You-Sung, et al.
Publicado: (2019) -
Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
por: Kishimoto, Hideaki, et al.
Publicado: (2015) -
Oral bisphosphonate compliance and persistence: a matter of choice?
por: Silverman, S. L., et al.
Publicado: (2010) -
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)